Review




Structured Review

PamGene International B.V microarray peptide assay
Microarray Peptide Assay, supplied by PamGene International B.V, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/peptide+microarray/pamchip+peptide+microarrays/ppr0830385-35-35-34
Average 90 stars, based on 1 article reviews
microarray peptide assay - by Bioz Stars, 2026-10
90/100 stars

Images

Related Articles

other:

Article Title: Kinome and mRNA expression profiling of high-grade osteosarcoma cell lines implies Akt signaling as possible target for therapy
Article Snippet: Kinome profiling was performed on 1 μg of cell lysate on the serine/threonine (Ser/Thr) Kinase PamChip® peptide microarrays (PamGene, ‘s-Hertogenbosch, the Netherlands) according to the manufacturer’s protocol, essentially as described in Hilhorst et al . [ ].

Article Title: Exploring antiproliferative activities and kinase profile of ortho-substituted N-(4-(2-(benzylamino)-2-oxoethyl)phenyl)benzamides.
Article Snippet: Yosra A. Muhammad and Abdelsattar M. Omar contributed equally to this work.. 1Department of Pharmaceutical Chemistry, Faculty of Pharmacy, King Abdulaziz University, Jeddah, Saudi Arabia 2Centre for Artificial Intelligence in Precision Medicines, King Abdulaziz University, Jeddah, Saudi Arabia 3Department of Pharmaceutical Chemistry, Faculty of Pharmacy, AlAzhar University, Cairo, Egypt 4Center of Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah, Saudi Arabia 5Faculty of Applied Medical Sciences, King Abdulaziz University, Jeddah, Saudi Arabia 6Department of Biochemistry, Faculty of Science, King Abdulaziz University, Jeddah, Saudi Arabia 7Department of Natural Products, Faculty of Pharmacy, King Abdulaziz University, Jeddah, Saudi Arabia

Article Title: Phosphocatalytic Kinome Activity Profiling of Apoptotic and Ferroptotic Agents in Multiple Myeloma Cells
Article Snippet: Tyrosine and serine-/threonine kinase profiles were determined by employing the PamChip ® peptide microarray system (Pamgene, s-Hertogenbosch, The Netherlands) according to the manufacturer’s instructions.

Article Title: ARID1A-induced transcriptional reprogramming rewires signalling responses to drug treatment in melanoma
Article Snippet: Protein Tyrosine Kinase (PTK) and Serine/Threonine Kinase (STK) activity profiles were assessed using PamChip® peptide microarrays (Pamgene International BV, BJ’s-Hertogenbosch, The Netherlands), which measure the ability of active kinases in a protein lysate to phosphorylate specific peptides imprinted on multiple peptide arrays.

Phospho-proteomics:

Article Title: Targeting ERBB3 and AKT to overcome adaptive resistance in EML4-ALK-driven non-small cell lung cancer
Article Snippet: .. To identify adaptive response mechanisms, we examined the landscape of tyrosine phosphorylation upon acute LOR treatment in EML4-ALK-positive NSCLC cell lines using PamGene microarray peptide assay, known as protein tyrosine kinase (PTK) (Fig. ). ..

Article Title: Targeting ERBB3 and AKT to overcome adaptive resistance in EML4-ALK non-small cell lung cancer
Article Snippet: .. Results Kinase activity pro ling revealed increased Tyrosine phosphorylation after lorlatinib treatment To identify adaptive response mechanisms, we examined the landscape of tyrosine phosphorylation upon acute lorlatnib treatment in EML4-ALK-positive NSCLC cell lines using PamGene microarray peptide assay, known as protein tyrosine kinase (PTK) (Fig. 1A). ..

Microarray:

Article Title: Targeting ERBB3 and AKT to overcome adaptive resistance in EML4-ALK-driven non-small cell lung cancer
Article Snippet: .. To identify adaptive response mechanisms, we examined the landscape of tyrosine phosphorylation upon acute LOR treatment in EML4-ALK-positive NSCLC cell lines using PamGene microarray peptide assay, known as protein tyrosine kinase (PTK) (Fig. ). ..

Article Title: Targeting ERBB3 and AKT to overcome adaptive resistance in EML4-ALK non-small cell lung cancer
Article Snippet: .. Results Kinase activity pro ling revealed increased Tyrosine phosphorylation after lorlatinib treatment To identify adaptive response mechanisms, we examined the landscape of tyrosine phosphorylation upon acute lorlatnib treatment in EML4-ALK-positive NSCLC cell lines using PamGene microarray peptide assay, known as protein tyrosine kinase (PTK) (Fig. 1A). ..

Activity Assay:

Article Title: Direct P70S6K1 inhibition to replace dexamethasone in synergistic combination with MCL-1 inhibition in multiple myeloma
Article Snippet: 30 Kinome analysis For kinomic profiling, HMCLs were lysed in M-PER mammalian protein extraction reagent (Thermo Fisher Scientific) containing Halt protease and Halt phosphatase inhibitor cocktails (Thermo Fisher Scientific). .. Analysis of serine/threonine kinase (STK) activity was performed by using the high-throughput peptide microarray system of the PamStation 12 platform (PamGene), according to the manufacturer’s instructions. .. Initial sample and array processing and image captures were performed by using Evolve software (PamGene).

Article Title: Kinome profiling analysis identified Src pathway as a novel therapeutic target in combination with histone deacetylase inhibitors for cutaneous T-cell lymphoma.
Article Snippet: Background: Histone deacetylase inhibitors (HDACi) are used to treat patients with cutaneous T-cell lymphoma (CTCL), but they show limited efficacy.. Hence, combination therapies should be explored to enhance the effectiveness of HDACis.. Objective: This study was conducted to identify novel therapeutic targets that can be combined with HDACis for treating CTCL.

Article Title: Targeting ERBB3 and AKT to overcome adaptive resistance in EML4-ALK non-small cell lung cancer
Article Snippet: .. Results Kinase activity pro ling revealed increased Tyrosine phosphorylation after lorlatinib treatment To identify adaptive response mechanisms, we examined the landscape of tyrosine phosphorylation upon acute lorlatnib treatment in EML4-ALK-positive NSCLC cell lines using PamGene microarray peptide assay, known as protein tyrosine kinase (PTK) (Fig. 1A). ..

Peptide Microarray:

Article Title: Direct P70S6K1 inhibition to replace dexamethasone in synergistic combination with MCL-1 inhibition in multiple myeloma
Article Snippet: 30 Kinome analysis For kinomic profiling, HMCLs were lysed in M-PER mammalian protein extraction reagent (Thermo Fisher Scientific) containing Halt protease and Halt phosphatase inhibitor cocktails (Thermo Fisher Scientific). .. Analysis of serine/threonine kinase (STK) activity was performed by using the high-throughput peptide microarray system of the PamStation 12 platform (PamGene), according to the manufacturer’s instructions. .. Initial sample and array processing and image captures were performed by using Evolve software (PamGene).

Article Title: Kinome profiling analysis identified Src pathway as a novel therapeutic target in combination with histone deacetylase inhibitors for cutaneous T-cell lymphoma.
Article Snippet: Background: Histone deacetylase inhibitors (HDACi) are used to treat patients with cutaneous T-cell lymphoma (CTCL), but they show limited efficacy.. Hence, combination therapies should be explored to enhance the effectiveness of HDACis.. Objective: This study was conducted to identify novel therapeutic targets that can be combined with HDACis for treating CTCL.



Similar Products

90
PEPperPRINT gmbh custom peptide microarrays
Custom Peptide Microarrays, supplied by PEPperPRINT gmbh, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/peptide+microarray/peptide+microarrays/us12331122-3204-0-6
Average 90 stars, based on 1 article reviews
custom peptide microarrays - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

90
PEPperPRINT gmbh pepperchip custom peptide microarray
Dot-plot between anti-CRP antibodies and epitope positivity. The graph displays anti-CRP antibodies versus the number of positive epitopes obtained with <t>microarray-based</t> linear epitope mapping in patients with systemic lupus erythematosus ( n =42). (CRP, C-reactive protein).
Pepperchip Custom Peptide Microarray, supplied by PEPperPRINT gmbh, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/peptide+microarray/pepperchip+peptide+microarrays/pmc12119686-100-18-22
Average 90 stars, based on 1 article reviews
pepperchip custom peptide microarray - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

90
JPT Peptide Technologies GmbH peptide microarrays
Dot-plot between anti-CRP antibodies and epitope positivity. The graph displays anti-CRP antibodies versus the number of positive epitopes obtained with <t>microarray-based</t> linear epitope mapping in patients with systemic lupus erythematosus ( n =42). (CRP, C-reactive protein).
Peptide Microarrays, supplied by JPT Peptide Technologies GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/peptide+microarray/peptide+microarrays/pm40111234-282-0-5
Average 90 stars, based on 1 article reviews
peptide microarrays - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

90
PEPperPRINT gmbh peptide microarray pepperchip® immunoassay protocol
Dot-plot between anti-CRP antibodies and epitope positivity. The graph displays anti-CRP antibodies versus the number of positive epitopes obtained with <t>microarray-based</t> linear epitope mapping in patients with systemic lupus erythematosus ( n =42). (CRP, C-reactive protein).
Peptide Microarray Pepperchip® Immunoassay Protocol, supplied by PEPperPRINT gmbh, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/peptide+microarray/pepperchip+peptide+microarrays/pm40324742-101-10-15
Average 90 stars, based on 1 article reviews
peptide microarray pepperchip® immunoassay protocol - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

90
PEPperPRINT gmbh pepperchip® peptide microarray platform
Dot-plot between anti-CRP antibodies and epitope positivity. The graph displays anti-CRP antibodies versus the number of positive epitopes obtained with <t>microarray-based</t> linear epitope mapping in patients with systemic lupus erythematosus ( n =42). (CRP, C-reactive protein).
Pepperchip® Peptide Microarray Platform, supplied by PEPperPRINT gmbh, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/peptide+microarray/pepperchip+peptide+microarrays/us12215168-867-13-7
Average 90 stars, based on 1 article reviews
pepperchip® peptide microarray platform - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

90
PEPperPRINT gmbh pepperchip© custom peptide microarray
Dot-plot between anti-CRP antibodies and epitope positivity. The graph displays anti-CRP antibodies versus the number of positive epitopes obtained with <t>microarray-based</t> linear epitope mapping in patients with systemic lupus erythematosus ( n =42). (CRP, C-reactive protein).
Pepperchip© Custom Peptide Microarray, supplied by PEPperPRINT gmbh, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/peptide+microarray/pepperchip+peptide+microarrays/pm39890694-45-31-28
Average 90 stars, based on 1 article reviews
pepperchip© custom peptide microarray - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

90
Immunodiagnostic Systems peptide microarrays
Dot-plot between anti-CRP antibodies and epitope positivity. The graph displays anti-CRP antibodies versus the number of positive epitopes obtained with <t>microarray-based</t> linear epitope mapping in patients with systemic lupus erythematosus ( n =42). (CRP, C-reactive protein).
Peptide Microarrays, supplied by Immunodiagnostic Systems, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/peptide+microarray/synthetic+peptides/pm39859531-1312-29-26
Average 90 stars, based on 1 article reviews
peptide microarrays - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

90
LC Sciences peptide microarray analysis
Dot-plot between anti-CRP antibodies and epitope positivity. The graph displays anti-CRP antibodies versus the number of positive epitopes obtained with <t>microarray-based</t> linear epitope mapping in patients with systemic lupus erythematosus ( n =42). (CRP, C-reactive protein).
Peptide Microarray Analysis, supplied by LC Sciences, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/peptide+microarray/custom+peptide+microarrays/us12194092-1329-2-8
Average 90 stars, based on 1 article reviews
peptide microarray analysis - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

90
PEPperPRINT gmbh peptide microarrays
Dot-plot between anti-CRP antibodies and epitope positivity. The graph displays anti-CRP antibodies versus the number of positive epitopes obtained with <t>microarray-based</t> linear epitope mapping in patients with systemic lupus erythematosus ( n =42). (CRP, C-reactive protein).
Peptide Microarrays, supplied by PEPperPRINT gmbh, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/peptide+microarray/peptide+microarrays/us12186380-48-1-8
Average 90 stars, based on 1 article reviews
peptide microarrays - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

90
PamGene International B.V microarray peptide assay
A Schematic model showing the PTK PamChip peptide <t>microarray</t> system and experimental design. B Heat map of up-and down-regulated Tyrosine (PTK assay) bait peptide phosphorylation of lorlatinib (4 h) versus DMSO treatment by peptide chip array ( n = 3 biological replicates) in H3122 and H2228 cell lines. Significant peptides ( p < 0.05) were clustered using hierarchical order and Euclidean/ward algorithm. C , D Volcano plots of the bait peptide phosphorylation from PTK chip arrays in A showing significant up- (Red) and downregulation (blue) of peptide phosphorylation as defined by ANOVA and post-hoc Dunnett’s test versus DMSO treatment ( p < 0.05). Non-significant peptides were highlighted in grey. Downregulated peptides were highlighted in light blue. ERBB family and AKT1 phosphopeptides were highlighted in green and black bold colours, respectively. E Venn diagram was generated to compare the phosphorylated Tyr peptides (up- and downregulated) after a 4 h treatment with lorlatinib in H3122 and H2228 cell lines. Tables of the specific phosphorylated Tyr sites and the associated proteins are shown. The down-regulated proteins were highlighted in cyan colour. The upregulated proteins selected for further analysis were highlighted in bold with green and black colours.
Microarray Peptide Assay, supplied by PamGene International B.V, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/peptide+microarray/pamchip+peptide+microarrays/pmc11655848-57-22-22
Average 90 stars, based on 1 article reviews
microarray peptide assay - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

Image Search Results


Dot-plot between anti-CRP antibodies and epitope positivity. The graph displays anti-CRP antibodies versus the number of positive epitopes obtained with microarray-based linear epitope mapping in patients with systemic lupus erythematosus ( n =42). (CRP, C-reactive protein).

Journal: Frontiers in Immunology

Article Title: Mapping autoantibody targets of full-length C-reactive protein in systemic lupus erythematosus: importance for neutrophil function and classical complement activation

doi: 10.3389/fimmu.2025.1578372

Figure Lengend Snippet: Dot-plot between anti-CRP antibodies and epitope positivity. The graph displays anti-CRP antibodies versus the number of positive epitopes obtained with microarray-based linear epitope mapping in patients with systemic lupus erythematosus ( n =42). (CRP, C-reactive protein).

Article Snippet: The full sequence of the CRP monomer was printed in 15 a.a sequences with 14 a.a overlap using PEPperCHIP Custom Peptide Microarray (PEPperPRINT ® GmbH, Heidelberg, Germany).

Techniques: Microarray

Heatmap representation of autoreactivity against CRP obtained with microarray-based linear epitope mapping of the full CRP monomer. (A, B) Individual signal intensity of IgG autoantibody reactivity against full-length CRP for subjects with SLE ( n =42) and HBD ( n =11). (C–E) Mean signal intensity of IgG autoantibody reactivity against motifs of full-length CRP comparing anti-CRP negative (anti-CRP–; n =16) vs. anti-CRP positive (anti-CRP+; n =26) patients with SLE, patients with ( n =6) and without ( n =36) active disease, and no damage ( n =20) vs. irreversible organ damage (any organ system; n =22). Each column represents one subject (A, B) or the mean value of a group (C–E) . Each row represents a 15 amino acid long sequence covering the full length of the protein with 14 amino acids overlap and 7 amino acid GS repeats elongated before and after the protein sequence. (CRP, C-reactive protein; HBD, healthy blood donors; SDI, Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index; SLE, systemic lupus erythematosus; SLEDAI-2K, SLE Disease Activity Index 2000).

Journal: Frontiers in Immunology

Article Title: Mapping autoantibody targets of full-length C-reactive protein in systemic lupus erythematosus: importance for neutrophil function and classical complement activation

doi: 10.3389/fimmu.2025.1578372

Figure Lengend Snippet: Heatmap representation of autoreactivity against CRP obtained with microarray-based linear epitope mapping of the full CRP monomer. (A, B) Individual signal intensity of IgG autoantibody reactivity against full-length CRP for subjects with SLE ( n =42) and HBD ( n =11). (C–E) Mean signal intensity of IgG autoantibody reactivity against motifs of full-length CRP comparing anti-CRP negative (anti-CRP–; n =16) vs. anti-CRP positive (anti-CRP+; n =26) patients with SLE, patients with ( n =6) and without ( n =36) active disease, and no damage ( n =20) vs. irreversible organ damage (any organ system; n =22). Each column represents one subject (A, B) or the mean value of a group (C–E) . Each row represents a 15 amino acid long sequence covering the full length of the protein with 14 amino acids overlap and 7 amino acid GS repeats elongated before and after the protein sequence. (CRP, C-reactive protein; HBD, healthy blood donors; SDI, Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index; SLE, systemic lupus erythematosus; SLEDAI-2K, SLE Disease Activity Index 2000).

Article Snippet: The full sequence of the CRP monomer was printed in 15 a.a sequences with 14 a.a overlap using PEPperCHIP Custom Peptide Microarray (PEPperPRINT ® GmbH, Heidelberg, Germany).

Techniques: Microarray, Sequencing, Activity Assay

A Schematic model showing the PTK PamChip peptide microarray system and experimental design. B Heat map of up-and down-regulated Tyrosine (PTK assay) bait peptide phosphorylation of lorlatinib (4 h) versus DMSO treatment by peptide chip array ( n = 3 biological replicates) in H3122 and H2228 cell lines. Significant peptides ( p < 0.05) were clustered using hierarchical order and Euclidean/ward algorithm. C , D Volcano plots of the bait peptide phosphorylation from PTK chip arrays in A showing significant up- (Red) and downregulation (blue) of peptide phosphorylation as defined by ANOVA and post-hoc Dunnett’s test versus DMSO treatment ( p < 0.05). Non-significant peptides were highlighted in grey. Downregulated peptides were highlighted in light blue. ERBB family and AKT1 phosphopeptides were highlighted in green and black bold colours, respectively. E Venn diagram was generated to compare the phosphorylated Tyr peptides (up- and downregulated) after a 4 h treatment with lorlatinib in H3122 and H2228 cell lines. Tables of the specific phosphorylated Tyr sites and the associated proteins are shown. The down-regulated proteins were highlighted in cyan colour. The upregulated proteins selected for further analysis were highlighted in bold with green and black colours.

Journal: Cell Death & Disease

Article Title: Targeting ERBB3 and AKT to overcome adaptive resistance in EML4-ALK-driven non-small cell lung cancer

doi: 10.1038/s41419-024-07272-7

Figure Lengend Snippet: A Schematic model showing the PTK PamChip peptide microarray system and experimental design. B Heat map of up-and down-regulated Tyrosine (PTK assay) bait peptide phosphorylation of lorlatinib (4 h) versus DMSO treatment by peptide chip array ( n = 3 biological replicates) in H3122 and H2228 cell lines. Significant peptides ( p < 0.05) were clustered using hierarchical order and Euclidean/ward algorithm. C , D Volcano plots of the bait peptide phosphorylation from PTK chip arrays in A showing significant up- (Red) and downregulation (blue) of peptide phosphorylation as defined by ANOVA and post-hoc Dunnett’s test versus DMSO treatment ( p < 0.05). Non-significant peptides were highlighted in grey. Downregulated peptides were highlighted in light blue. ERBB family and AKT1 phosphopeptides were highlighted in green and black bold colours, respectively. E Venn diagram was generated to compare the phosphorylated Tyr peptides (up- and downregulated) after a 4 h treatment with lorlatinib in H3122 and H2228 cell lines. Tables of the specific phosphorylated Tyr sites and the associated proteins are shown. The down-regulated proteins were highlighted in cyan colour. The upregulated proteins selected for further analysis were highlighted in bold with green and black colours.

Article Snippet: To identify adaptive response mechanisms, we examined the landscape of tyrosine phosphorylation upon acute LOR treatment in EML4-ALK-positive NSCLC cell lines using PamGene microarray peptide assay, known as protein tyrosine kinase (PTK) (Fig. ).

Techniques: Peptide Microarray, Generated